As of January 2026 Orchestra BioMed has a market cap of โน24.44 Billion. This makes Orchestra BioMed the world's 8121th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jan 11th, 2026 the market cap of Orchestra BioMed was reported to be: